Anti-CD30 antibody

Catalog Number:
STJ180051
Price:
$641
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • CD30, a single chain glycoprotein, is synthesized as a 90kDa precursor which is processed in the Golgi complex into a membrane‐bound phosphorylated mature 105/120kDa glycoprotein. The CD30/Ki‐1 antigen is expressed by mononuclear Hodgkin and multinucleated Reed‐Sternberg cells in Hodgkin’s disease, by the tumor cells of a majority of anaplastic large cell lymphomas, and by a varying proportion of activated T and B cells. Ber‐H2 distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. About one third of the Ki‐1 positive lymphomas lack the leukocyte common antigen (CD45).

          Please contact us at  for specific academic pricing.

      • Properties
        • Host
          mouse
          Antibody Type
          monoclonal
          Isotype
          IgG1 kappa
          Reactivity
          human
          Clone
          Ber‐H2
          Immunogen
          Co cell line established from a patient with Hodgkin's disease of T‐cell lineage
          Conjugate
          Unconjugated
          Formulation
          Purified antibody diluted in Tris‐HCI buffer containing stabilizing protein and <0.1% sodium azide.
          Storage
          Store at 2-8°C for up to 1 year
          Regulatory Status
          RUO
          Antigen
          Tumor Necrosis Factor Receptor Superfamily Member 8; Cd30l Receptor; Ki-1 Antigen; Lymphocyte Activation Antigen Cd30; Cd Antigen Cd30 (Gene ID:943; UniProt:P28908)

          * For research use only

      • Applications
        • Application
          IHC (paraffin)
        • Application Dilutions
          IHC (paraffin) 1:100‐200
    Copyright © Amerigo Scientific. All rights reserved.